我的生活+的主要目标之一是帮助人们预防新的HIV和其他STI,丙型肝炎和结核病病历的产生。

该应用程序有助于建立医生和HIV感染者之间的匿名沟通。 它可以让您创建简单易行的服药时间表,并设置隐藏和个性化的提醒。

返回
28 三月 2017, 09:24
2399

U.S. National Cancer Institute Establishes Biobank For HIV Malignancy Research in Sub-Saharan Africa

U.S. National Cancer Institute Establishes Biobank For HIV Malignancy Research in Sub-Saharan Africa - 图片 1

The Sub-Saharan Africa Regional Biorepository aims to collect proactively, manage and process biospecimens representing both AIDS-defining cancers (e.g., Kaposi’s sarcoma, non-Hodgkin lymphoma, cervical cancer) and non-AIDS-defining cancers (e.g., lung cancer, breast cancer, colon cancer), as well as associated clinical data. The biobank established in the Division of Anatomical Pathology, National Health Laboratory Service (NHLS), at Tygerberg Academic Hospital, a teaching hospital for the Faculty of Medicine and Health Sciences at Stellenbosch University in Cape Town, South Africa.

Sub-Saharan Africa has one of the highest incidences of HIV infection in the world. Despite improved life expectancy from increased access to antiretroviral therapy, the region will most likely see an increase in HIV-associated cancers, as is currently the case in many developed countries. The researchers hope collected biological samples will help to speed up HIV malignancy research.

The long-term plans of the Sub-Saharan Africa Regional Biorepository include collecting specimens from other sites in the Western and Eastern Cape provinces as well as the rest of South Africa, and eventually all of Sub-Saharan Africa. It is a resource that will benefit researchers, patients and communities in Africa. Through collaboration, the biobank will also develop unique specimen collections and clinical data sets to promote multi-institutional collaborative research in HIV-related cancers.

作者: Marina Shegay

在社交媒体上分享